StonvexLoading…
StonvexStonvexStonvexCore line items from NHPAP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $342.28M | $353.79M | $345.93M | $335.85M |
Operating Income | $3.30M | $-123.54M | $-4.74M | $-31.54M |
Net Income | $-57.69M | $-190.26M | $-72.38M | $-79.62M |
EPS (Diluted) | $-2.51 | $-7.19 | $-3.04 | $-3.30 |
Total Assets | $1.71B | $1.95B | $2.15B | $2.18B |
Total Liabilities | $1.11B | $1.26B | $1.24B | $1.18B |
Cash & Equivalents | $57.62M | $21.65M | $46.41M | $53.65M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 28.43M | 28.30M | 27.89M | 26.27M |